Join to View Full Profile
333 Cottman AveFox Chase Cancer CenterPhiladelphia, PA 19111
Phone+1 215-728-6900
Fax+1 215-728-5336
Dr. Engstrom is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MinnesotaResidency, Internal Medicine, 1963 - 1967
M Health FairviewInternship, Transitional Year, 1962 - 1963- University of Minnesota Medical SchoolClass of 1962
Certifications & Licensure
PA State Medical License Active through 2021
NJ State Medical License 1972 - 2019
MN State Medical License 1963 - 2001
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer Start of enrollment: 1990 Dec 07
- Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia Start of enrollment: 2003 Nov 01
- Molecular Analysis in Tissue Samples From Patients With Advanced or Metastatic Neuroendocrine Tumors Start of enrollment: 2013 Oct 16
Publications & Presentations
PubMed
- 7 citationsImpacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasms.Alexander W. MacFarlane, Ho Man Yeung, R. Katherine Alpaugh, Essel Dulaimi, Paul F. Engstrom
Cancer Immunology, Immunotherapy. 2021-01-04 - 79 citationsPembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trialsNamrata Vijayvergia, Arvind Dasari, Mengying Deng, Samuel Litwin, Taymeyah Al-Toubah
British Journal of Cancer. 2020-03-10 - 27 citationsGenomic profiling of NETs: a comprehensive analysis of the RADIANT trialsJames C. Yao, Abhishek Garg, David Chen, Jaume Capdevila, Paul F. Engstrom
Endocrine-Related Cancer. 2019-04-01
Press Mentions
- Navigating the Intersection Between Genomic Research and Clinical PracticeAugust 8th, 2020
Honoring Paul F. Engstrom, MD: A Pioneer of Cancer PreventionMarch 4th, 2020
Paul F. Engstrom, MD, Named a Lifetime Achiever by Marquis Who's WhoOctober 6th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
